You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

Litigation Details for ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited (D. Del. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited
The small molecule drug covered by the patents cited in this case is ⤷  Subscribe .

Details for ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2020-07-30 1 Complaint United States Patent Nos. 7,732,615 (“the ’615 patent”) and 10,646,480 (“the ’480 patent”) (collectively…collectively “the patents-in-suit”). This action arises under the Patent Laws of the United States, 35 U.S.C.…ACADIA owns the ’615 patent. 26. On May 12, 2020, the ’480 patent, entitled “Formulations…of the ’480 patent is attached as Exhibit B. 27. ACADIA owns the ’480 patent. … respect to the patents-in-suit constituted an act of infringement of those patents. 43. External link to document
2020-09-30 11 Counterclaim AND Answer to Complaint claim of U.S. Patent No. 7,732,615; (c) declaring that the claims of U.S. Patent No. 7,732,615 are invalid….S. Patent Nos. 7,732,615 (“the ’615 patent”) and 10,646,480 (“the °480 patent”) under the Patent Laws…United States Patent Nos. 7,732,615 (“the °615 patent”) and 10,646,480 (“the ’480 patent”) (collectively…infringement of U.S. Patent Nos. 7,732,615 (“the ’615 patent”) and 10,646,480 (“the ’480 patent”) arising under… any valid and enforceable claim of U.S. Patent No. 7,732,615; (b) declaring that the manufacture, use External link to document
2020-11-04 17 Complaint - Amended States Patent Nos. 7,732,615 (“the ’615 patent”), 10,646,480 (“the ’480 patent”), and 7,601,740 (“the …the ’740 patent”) (collectively “the patents-in-suit”). This action arises under the Patent Laws of the…ACADIA owns the ’615 patent. 26. On May 12, 2020, the ’480 patent, entitled “Formulations…of the ’480 patent is attached as Exhibit B. 27. ACADIA owns the ’480 patent. …of the ’740 patent is attached as Exhibit C. 29. ACADIA owns the ’740 patent. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.